Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Basel

5th Clinic Meets Data Science Symposium

The 5th Clinic Meets Data Science Symposium will present current progress in clinical data science, emphasizing cutting-edge and future applications alongside relevant tools. It will [...]

Go to Top